VoxCell BioInnovation takes the crown at the last-ever Collision PITCH competition
VoxCell’s 3D bioprinted imitation of natural soft tissue helps pharmaceutical companies test new drugs faster.
VoxCell’s 3D bioprinted imitation of natural soft tissue helps pharmaceutical companies test new drugs faster.
Experts at Collision 2024 weighed in on the AI hype cycle, enterprise adoption, and doomsday scenarios.
Canada’s anti-money laundering agency fined the crypto exchange in May for registration and reporting failures.
The deals, if successful, will have a combined value of over $36 million.
Letartre joined Accelia in 2022, bringing experience from Caisse de dépôt et placement du Québec.
Despite a pool of just 4,000, Canada still represents five percent of the world’s quantum talent.
How ventureLAB is helping a Chilean quantum tech startup break into the Canadian market.
VCs at Collision 2024 speak about AI and valuations in the post-post-boom times.
Propulso says the funding has already allowed it to double its workforce.
Feds, province, City of Vancouver pledge up to $14.8 million over three years to Collision’s successor.
New company follows the recent exodus of safety-focused employees at OpenAI.
Each startup is receiving between $150,000 to $500,000 based on company stage, needs, and evaluation processes.
Commitment includes two $100-million CAD platforms to support Indigenous, Black-led businesses.
Heylist, Vosyn, Pok Pok, and Ability Biologics have all raised fresh capital.
New fund will invest in projects solving pressing challenges for Indigenous communities.